CDKAL1 and HHEX are associated with type 2 diabetes-related traits among Yup'ik people

Journal of Diabetes

Volumn 6, Issue 3, 2014, Pages 251-259

  Klimentidis, Yann C ^a   Lemas, Dominick J ^b   Wiener, Howard H ^c   O'Brien, Diane M ^e   Havel, Peter J ^c,e   Stanhope, Kimber L ^c,e   Hopkins, Scarlett E ^e   Tiwari, Hemant K ^d   Boyer, Bert B ^e  

^a UNIVERSITY OF ARIZONA   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALASKA FAIRBANKS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alaska Native; Glycemic traits; N 3 polyunsaturated fatty acids; Type 2 diabetes single nucleotide polymorphisms

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; PROTEIN CDKAL 1; PROTEIN HHEX; SOMATOMEDIN B; UNCLASSIFIED DRUG; CDKAL1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 5; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HHEX PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; INSULIN; TRANSCRIPTION FACTOR;

ADULT; ALLELE; ARTICLE; BODY MASS; FAT INTAKE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRAIT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL FUNCTION; PHENOTYPE; PRIORITY JOURNAL; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID ADENOMA; UNITED STATES; BLOOD; DIET; DIET RESTRICTION; EPIDEMIOLOGY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INUIT; METABOLISM; MIDDLE AGED; PREVALENCE; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADULT; ALASKA; BLOOD GLUCOSE; BODY MASS INDEX; CYCLIN-DEPENDENT KINASE 5; DIABETES MELLITUS, TYPE 2; DIET; FASTING; FATTY ACIDS, OMEGA-3; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; INUITS; LINEAR MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84898597484     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12093     Document Type: Article

References (55)

1. Narayanan ML, Schraer CD, Bulkow LR etal. Diabetes prevalence, incidence, complications and mortality among Alaska Native people 1985-2006. Int J Circumpolar Health. 2010; 69: 236-252.
2. Carter EA, MacCluer JW, Dyke B etal. Diabetes mellitus and impaired fasting glucose in Alaska Eskimos: The Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Diabetologia. 2006; 49: 29-35.
3. Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol. 1978; 108: 497-505.
4. Schraer CD, Risica PM, Ebbesson SO, Go OT, Howard BV, Mayer AM. Low fasting insulin levels in Eskimos compared to American Indians: Are Eskimos less insulin resistant? Int J Circumpolar Health. 1999; 58: 272-280.
5. Boyer BB, Mohatt GV, Plaetke R etal. Metabolic syndrome in Yup'ik Eskimos: The Center for Alaska Native Health Research (CANHR) Study. Obesity. 2007; 15: 2535-2540.
6. Alaska Department of Health and Social Services. Health risks in Alaska among adults. Alaska behavioral risk factor survey. 2009 annual report. Available from: http://dhss.alaska.gov/dph/Chronic/Documents/brfss/pubs/BRFSS09_FullReport.pdf (accessed 20 April 2012).
7. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia. 1987; 30: 763-768.
8. Mills GW, Avery PJ, McCarthy MI etal. Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia. 2004; 47: 732-738.
9. Zeggini E, Scott LJ, Saxena R etal. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40: 638-645.
10. Voight BF, Scott LJ, Steinthorsdottir V etal. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42: 579-589.
11. Dupuis J, Langenberg C, Prokopenko I etal. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42: 105-116.
12. Waters KM, Stram DO, Hassanein MT etal. Consistent association of type 2 diabetes risk variants found in europeans in diverse racial and ethnic groups. PLoS Genet. 2010; 6: e1001078.
13. Lewis JP, Palmer ND, Hicks PJ etal. Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes. 2008; 57: 2220-2225.
14. Lin Y, Li P, Cai L etal. Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population. BMC Med Genet. 2010; 11: 97.
15. Yan Y, North K, Heiss G. Transcription Factor 7-Like 2 (TCF7L2) polymorphism and context-specific risk of impaired fasting glucose in African American and Caucasian adults: The atherosclerosis risk in communities (ARIC). Diabetes. 2010; 2: 371-377.
16. Nettleton JA, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review. J Am Diet Assoc. 2005; 105: 428-440.
17. Johnson JS, Nobmann ED, Asay E, Lanier AP. Dietary intake of Alaska Native people in two regions and implications for health: The Alaska Native Dietary and Subsistence Food Assessment Project. Int J Circumpolar Health. 2009; 68: 109-122.
18. O'Brien DM, Kristal AR, Jeannet MA, Wilkinson MJ, Bersamin A, Luick B. Red blood cell δ15N: A novel biomarker of dietary eicosapentaenoic acid and docosahexaenoic acid intake. Am J Clin Nutr. 2009; 89: 913-919.
19. Makhoul Z, Kristal AR, Gulati R etal. Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids. Eur J Clin Nutr. 2011; 65: 808-817.
20. Morris AP, Voight BF, Teslovich TM etal. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44: 981-990.
21. Scott R, Lagou V, Welch RP etal. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012; 44: 991-1005.
22. Simonis-Bik AMC, Eekhoff EMW, Diamant M etal. The heritability of HbA1c and fasting blood glucose in different measurement settings. Twin Res Hum Genet. 2008; 11: 597-602.
23. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD. HbA(1c) levels are genetically determined even in type 1 diabetes: Evidence from healthy and diabetic twins. Diabetes. 2001; 50: 2858-2863.
24. Sladek R, Rocheleau G, Rung J etal. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445: 881-885.
25. Saxena R, Voight BF, Lyssenko V etal. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316: 1331-1336.
26. Steinthorsdottir V, Thorleifsson G, Reynisdottir I etal. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007; 39: 770-775.
27. Zeggini E, Weedon MN, Lindgren CM etal. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007; 316: 1336-1341.
28. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Human Kinetics Pub., Champaign, IL, 1988.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419.
30. Sato KK, Hayashi T, Harita N etal. Combined measurement of fasting plasma glucose and A1c is effective for the prediction of type 2 diabetes. Diabetes Care. 2009; 32: 644-646.
31. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care. 2000; 23: 1770-1773.
32. Lemas DJ, Wiener HW, O'Brien DM etal. Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos. J Lipid Res. 2011; 53: 175-184.
33. Tang K, Fu D-J, Julien D, Braun A, Cantor CR, Köster H. Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci USA. 1999; 96: 10016-10020.
34. Lemas DJ, Klimentidis YC, Wiener HH etal. Obesity polymorphisms identified in genome-wide association studies interact with n-3 polyunsaturated fatty acid intake and modify the genetic association with adiposity phenotypes in Yup'ik people. Genes Nutr. 2013; 8: 495-505.
35. Lange K, Papp JC, Sinsheimer JS, Sripracha R, Zhou H, Sobel EM. Mendel: The Swiss army knife of genetic analysis programs. Bioinformatics. 2013; 29: 1568-1570.
36. The International HapMap Consortium. The international HapMap project. Nature. 2003; 426: 789-796.
37. Aslibekyan S, Vaughan L, Wiener H etal. Evidence for novel genetic loci associated with metabolic traits in Yup'ik people. Am J Hum Biol. 2013; 25: 673-680.
38. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Ser B Stat Methodol. 1964; 26: 211-252.
39. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2011. Available from: http://www.r-project.org (accessed January 2012).
40. Ryoo H, Woo J, Kim Y, Lee C. Heterogeneity of genetic associations of CDKAL1 and HHEX with susceptibility of type 2 diabetes mellitus by gender. Eur J Hum Genet. 2011; 19: 672-675.
41. Centers for Disease Control. National diabetes fact sheet, 2011. Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf (accessed 15 June 2012).
42. Chistiakov DA, Potapov VA, Smetanina SA, Bel'chikova LN, Suplotova LA, Nosikov VV. The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel. Acta Diabetol. 2011; 48: 227-235.
43. Pascoe L, Tura A, Patel SK etal. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes. 2007; 56: 3101-3104.
44. Ryu J, Lee C. Association of glycosylated hemoglobin with the gene encoding CDKAL1 in the Korean Association Resource (KARE) study. Hum Mutat. 2012; 33: 655-659.
45. Miyaki K, Oo T, Song Y etal. Association of a cyclin-dependent kinase 5 regulatory subunit-associated protein 1-like 1 (CDKAL1) polymorphism with elevated hemoglobin A1(c) levels and the prevalence of metabolic syndrome in Japanese men: Interaction with dietary energy intake. Am J Epidemiol. 2010; 172: 985-991.
46. Bort R, Martinez-Barbera JP, Beddington RS, Zaret KS. Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. Development. 2004; 131: 797-806.
47. Sim X, Ong RT, Suo C etal. Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from southeast Asia. PLoS Genet. 2011; 7: e1001363.
48. Rong R, Hanson RL, Ortiz D etal. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes. 2009; 58: 478-488.
49. Lin P-I, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: The flip-flop phenomenon. Am J Hum Genet. 2007; 80: 531-538.
50. Hu C, Zhang R, Wang C etal. Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion. PLoS ONE. 2010; 5: e11761.
51. Langenberg C, Pascoe L, Mari A etal. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia. 2009; 52: 1537-1542.
52. Lyssenko V, Nagorny CLF, Erdos MR etal. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet. 2009; 41: 82-88.
53. Dubocovich ML. Melatonin receptors: Role on sleep and circadian rhythm regulation. Sleep Med. 2007; 8 (Suppl. 3): 34-42.
54. Marselli L, Trincavelli L, Santangelo C etal. Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res. 2008; 151: 273-279.
55. Soranzo N. Genetic determinants of variability in glycated hemoglobin (HbA(1c)) in humans: Review of recent progress and prospects for use in diabetes care. Curr Diab Rep. 2011; 11: 562-569.